Management of Newly Diagnosed ALS
All adults newly diagnosed with ALS should be immediately enrolled in multidisciplinary care and started on disease-modifying therapy, with palliative care integrated from the time of diagnosis. 1, 2
Immediate Actions at Diagnosis
1. Multidisciplinary Care Enrollment (Priority #1)
- Refer immediately to a specialized ALS multidisciplinary clinic - this is the single most impactful intervention, improving both survival (4-7 months) and quality of life 3, 2
- The team must include: neurologist, nurse coordinator, physical/occupational/speech therapists, dietitian, respiratory therapist, and social worker 2, 4
- Do not delay this referral - late referral to specialized services negatively impacts patient and caregiver quality of life 5
2. Disease-Modifying Pharmacotherapy
Start riluzole immediately upon diagnosis 3, 2, 4:
- Slows progression by 2-4 months
- Most established evidence base
- Should be initiated before awaiting genetic testing results
Additionally consider edaravone (oral or IV formulation) 3, 6:
- Can be used in combination with riluzole
- Japan now uses up to 3-4 agents simultaneously, though long-term combination data is limited 6
Genetic testing is mandatory for all ALS patients 6:
- 15% have familial ALS 3
- If SOD1 pathogenic variant identified: tofersen (intrathecal antisense oligonucleotide) is indicated 3, 6
- C9orf72 variants account for 40% of familial cases 3
- Requires genetic counseling regarding ethical/psychological implications 6
3. Palliative Care Integration from Diagnosis
Critical pitfall: Do NOT wait for end-stage disease to involve palliative care 5
- Palliative approach should begin at diagnosis, not just terminal phase 5, 4
- Early referral allows time to establish relationships and address end-of-life planning before crisis 5
- This improves quality of life for both patients and caregivers 5
Ongoing Proactive Management (Stage-Responsive)
Respiratory Management
- Monitor forced vital capacity (FVC) regularly 1, 2
- Initiate non-invasive positive pressure ventilation (NIV) before FVC drops below 50% - current Medicare criteria requiring <50% FVC is outdated and harmful 1
- NIV improves both survival and quality of life 4
- Arrange in-home respiratory care services 1
Nutritional Support
- Place PEG tube before respiratory insufficiency develops (typically when FVC >50%) 4
- PEG improves nutrition and quality of life 4
- Waiting too long increases procedural risk
Communication
- Assess communication needs continuously - maintaining ability to communicate is essential 4
- Provide augmentative communication devices proactively, not reactively 7
Home-Based Care
The 2026 AANEM guideline emphasizes anticipatory, stage-responsive home care rather than reactive care 7:
- Home health nursing for medication management, symptom monitoring
- Physical/occupational therapy for mobility and ADL adaptations
- Speech-language pathology for swallowing/communication
- Durable medical equipment (mobility aids, hospital bed, lifts) provided proactively 7
Symptom Management
Address common symptoms aggressively 2, 4:
- Sialorrhea (excessive saliva)
- Pseudobulbar affect (emotional lability)
- Muscle cramps and spasticity
- Pain (often underrecognized)
- Thick mucus
Advance Care Planning
Discuss advance directives early, not in crisis 4:
- Patient autonomy must be maintained throughout disease course
- Address ventilation preferences, end-of-life wishes
- Respect cultural and social background 4
- Caregiver support is essential - unpaid caregivers need resources 1
System-Level Considerations
The 2024 NASEM report highlights structural barriers 1:
- Black Americans face significantly worse ALS outcomes - centers should partner with community organizations to improve equity 1
- Hub-and-spoke care model recommended: comprehensive centers, regional centers, and community-based clinics to expand access 1
- Value-based payment models needed to incentivize quality multidisciplinary care 1
Key Pitfalls to Avoid
- Delaying multidisciplinary care referral - this is the most evidence-based intervention
- Waiting for respiratory crisis before NIV - proactive initiation is superior
- Delaying PEG until respiratory compromise - increases risk
- Treating palliative care as "end-of-life only" - it should start at diagnosis
- Failing to perform genetic testing - misses opportunity for targeted therapy (tofersen)
- Reactive rather than anticipatory equipment/service provision - leads to preventable complications 7